8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...

26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...

17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...

French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...

This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...

Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK ...

Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and ...

David Gindler of Orrick discusses the US Supreme Court’s ruling in Amgen v. Sanofi and what it means for ongoing Section 112 ...

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, ...

11 January 2022 Alexion, AstraZeneca’s rare disease group, has entered into an exclusive licensing agreement with Neurimmune ...

Regeneron files motion to disqualify firm from patent and antitrust dispute | Motion cites conflict of interest due to ...

Despite efforts to harmonise, the Unified Patent Court’s local divisions and Court of Appeal have signalled a divergence over ...